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Methicillin-resistant Staphylococcus aureus (MRSA) commonly causes infection in hospitalized patients. Since its
appearance in the 1960s, the SCCmec has evolved throughout the years into 5 different types (I-V), each bearing a
different set of genes. Infection with MRSA SCCmec types I, II or III is almost exclusively restricted to hospitalised
patients. However, recently, community acquired MRSA (CA-MRSA) infections have been reported with increasing
frequency, usually caused by a type IV SCCmec MRSA in nosocomial settings. We studied the prevalence of SCCmec
types in 50 nosocomial strains collected from 1995 to 1999. The SCCmec complex type and presence of Panton-
Valentine leukocidin (PVL) were determined by PCR. Strains had been previously typed by PFGE and were now
typed by MLST. We found that 3 of the isolates studied bore a type IVc SCCmec all having different PFGE and MLST
profiles (ST3, ST5 and ST88). All strains bearing a type III SCCmec belonged to MLST ST239 (Brazilian/Iberian
clone). Only the strain which presented the ST5 profile bore the pvl gene. The type IVc SCCmec strains presented
relatively lower levels of resistance to oxacillin in comparison to the type III SCCmec strains. The pattern of
dissemination of the type IV SCCmec remains to be elucidated. The finding of strains carrying a type IV SCCmec
in the present study among strains isolated at least 7 years ago indicates that clones bearing a type IV SCCmec have
been present in Brazil for quite some time, and must have gone by undetected.
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Methicillin-resistant Staphylococcus aureus (MRSA) has
established itself as one of the most important nosocomial
pathogens in that it is expressively prevalent in the hospital
environment and poses a challenge to antibiotic
chemotherapy due to its multi-resistant profile. MRSA
commonly causes infection in hospitalized patients who
possess risk factors for the acquisition of this pathogen [1].
Methicillin resistance in S. aureus is conferred by the mecA
gene, which is itself carried in a mobile genetic element called
the staphylococcal cassette chromosome mec (SCCmec) [2].
Since its appearance in the 1960s, the SCCmec has evolved
throughout the years into 5 different types (I-V), each bearing
a different set of genes. Until recently, infection with MRSA
was an event almost exclusively restricted to hospitalised
patients, with most nosocomial MRSA strains bearing one of
three types of SCCmec, either type I, II or III [3]. However,
MRSA community infections have been reported with
increasing frequency [4-6]. These infections, which are
clinically similar to the ones caused by methicillin susceptible
S. aureus (MSSA), usually affect individuals who do not bear
the risk factors for the acquisition of MRSA [7]. Strains causing
these infections are designated community acquired MRSA
or CA-MRSA. These strains are usually more susceptible to
antibiotics of different classes than their nosocomial
counterparts and are represented by a larger number of
different clones [7-9].
The CA-MRSA strains possess a SCCmec type
designated type IV, which is physically smaller than the other
SCCmec types and does not carry antimicrobial resistance
genes other than the mecA gene [10]. They are usually more
virulent than nosocomial MRSA, which, combined with their
resistance to beta-lactams turns them into a menace, for
infection can be fatal as has been previously reported [4].
An endemic MRSA clone has been shown to be widely
disseminated throughout Brazilian hospitals. This clone is
known as the Brazilian Endemic Clone (BEC) and has also
been found to be disseminated elsewhere in South America,
as well as in Europe [11,12]. This well characterised clone has
been described as ST239 when typed by Multilocus Sequence
Typing (MLST) [13], and carries a type III SCCmec [14].
Previous studies [15-17] describing the prevalence and
extension of geographic dissemination of this single MRSA
clone in Brazil showed it to represent close to 80% of MRSA
isolates. This clone was reported as being the most frequent
among MRSA isolates recovered from several hospitals from
several cities located throughout Brazil’s enormous territory
and separated by a distance of several thousand kilometres.
Souza et al. [11] also reported the predominance (97%) and
persistence of this clone among isolates in Brazil. Using Pulsed
Field Gel Electrophoresis (PFGE), the BEC has been broken
down into different subtypes all related to one another [11],
which could be explained by its maintenance in Brazil at least
since 1990 [17].
Material and Methods
Bacterial Isolates
The bacterial strains used in this study were selected from
a collection obtained in a previous study [18] lasting four
years (1995 to 1999), in which approximately 300 MRSA strains
were collected in a multi-centre investigation involving 27
hospitals in several Brazilian cities. The strains were isolated
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from different human clinical samples, from colonization or
infection without duplication of single patient, and were
characterized by PFGE using SmaI, taking into consideration
the criteria proposed by Tenover [19]. Approximately 80% of
the isolates belonging to this collection had presented the
same profile by PFGE (considered to be the BEC), whereas the
remainder presented another 9 different profiles.
For the present study, 50 strains were selected from this
collection in order to represent the 10 different PFGE clones
found by Oliveira et al. [18] These 9 remaining clones
presented a more susceptible profile to antibiotics when
compared to BEC. Isolates were tested for resistance to
oxacillin and vancomycin using the agar dilution method
according to the Clinical and Laboratory Standard Institute
(CLSI, formerly NCCLS) guidelines [20].
Determination of SCCmec Complex
The SCCmec complex type was determined by
polymerase chain reaction (PCR). The primers used for the
classification of type IV SCCmec into IVa and IVb subtypes
were most kindly provided by Dr. T. Ito [10]. For determining
SCCmec  subtype IVc, primers IVcF (5’-
tctattcaatcgttctcgtattt-3’) and IVcR (5’-
tcgttgtcatttaattctgaact-3’), also provided by Dr. Ito, were
used as described previously [10].
MLST
MLST was performed as described previously [21] in
order to determine the lineage of some strains.
Determination of the PVL Gene
Presence of the pvl gene, which codes for PVL (suggested
as a marker for type IV SCCmec) [22], was determined by
using specific primers as previously described [23]. Strain
MR108 was used as a positive control for this reaction.
Results
The types of SCCmec found for each strain as well as
MLST strain type are described in Table 1. The majority of
strains presented a type III SCCmec. Three isolates bore a
type IVc SCCmec, all having different PFGE profiles. The
three type IVc SCCmec strains had been isolated from clinical
specimens obtained from a navel abscess, from a surgical
wound secretion and from pleural fluid. As expected, isolates
carrying a type IVc SCCmec showed resistance to a lower
number of antimicrobial agents belonging to different classes,
compared to the other type III SCCmec strains and seemed
not to be genetically related.
All strains bearing a type III SCCmec were typed by
MLST as belonging to ST239, which is the profile of the
BEC. The strains bearing a type IVc SCCmec, all presented
profiles different to that of the BEC. These strains were
characterised as ST3, ST5 and ST88. Of these strains, only
the strain which presented the ST5 profile bore the pvl
gene.
Discussion
The type IVc SCCmec ST3 and ST5 strains presented
relatively lower levels of resistance to oxacillin (MICs of 8 and
64 mg/mL, respectively) in comparison to the type III SCCmec
strains, which presented MICs >512 µg/mL.
MLST grouped several different PFGE profiles (A, B, E, H,
I, K and M) into a single strain type (ST239), which indicates
that MLST’s discriminatory power may be lower than that of
PFGE. ST239 could thus be broken down into 7 different
lineages, which would be invaluable in regional or institutional
epidemiological studies. However, MLST unambiguously
relates these 7 PFGE profiles with other globally present
strains. It thus seems that PFGE is a good technique to analyse
a small number of isolates obtained during outbreaks occurring
in hospitals or communities in a relatively short period of time
(1 to 3 months), because its greater discriminatory power would
ensure the detection of lateral transmission even between
strains belonging to ST239 determined by MLST [24]. On the
other hand MLST is an excellent tool for investigating the
clonal evolution of MRSA. The low number of strains used in
this study probably does not allow the assessment of the
merits of comparisons of these two methods.
PVL has consistently been found in CA-MRSA strains,
so much so that it has been proposed as an epidemiological
marker for CA-MRSA strains [22]. Studies have shown the
physiopathological involvement of PVL in skin infections and
necrotising pneumonia [25,26]. Out of three type IVc SCCmec
strains identified in this present study, only one bore the pvl
gene. This strain had been isolated from pleural fluid.
Unfortunately we did not have the opportunity to follow this
case. The other type IVc SCCmec strains found did not bear
the pvl gene and had been isolated from a surgical wound
secretion and a navel abscess.
The finding of type IV SCCmec in nosocomial strains in
Brazil should be, like the emergence of VISA [27], of great
concern to the medical community. CA-MRSA is emerging
as significant community pathogens, especially in
previously healthy children who bear no recognizable risk
factors. It is predominantly associated with skin and soft
tissue infections (especially abscesses and cellulitis).
When present, risk factors are generally similar to those
for infection with MSSA [28]. Some CA-MRSA strains have
entered the hospital environment and caused outbreaks of
infection, which has led to difficulty in distinguishing these
strains from traditional nosocomial ones. CA-MRSA strains
usually bear genes for PVL, which is associated with
furunculosis and necrotizing pneumonia, and sometimes
possess other virulence genes such as those for toxic shock
syndrome or exfoliative toxins [29]. The pattern of
dissemination of the type IV SCCmec remains to be
elucidated. Whether the flow of type IV SCCmec strains is
greater from the community to the hospital environment or
vice versa is still unknown and might be revealed in future
studies. What also remains to be determined is whether it
might give rise to other SCCmec types in the future by
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gaining or losing some of its genes. Indeed, other SCCmec
types (V) have already been described. Whether these new
types evolved from the type IV SCCmec or from the other
older types (I to III) is still unknown.
Recently, a case of CA-MRSA strains isolated from a
community infection in Brazil was reported [30]. The finding of
strains carrying a type IV SCCmec in the present study among
strains isolated at least 7 years ago, and moreover the report of
a recent outbreak of type IV SCCmec strains at a Brazilian
university hospital, reported by Trindade et al. [31], indicates
that clones bearing a type IV SCCmec have been present in
Brazil for quite some time, and must have escaped undetected.
These strains are disseminating in hospitals where they may be
adapting to vanquish the intense antimicrobial selective
pressure present in a nosocomial environment. The detection
and monitoring of strains carrying a type IV SCCmec in both
hospital and community environments is crucial if we are to
better understand their epidemiology and ultimately control
their dissemination.
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